The angular structure of ONC201, a TRAIL pathway-inducing compound, determines its potent anti-cancer activity-Reference-Cited by-同舟云学术

The angular structure of ONC201, a TRAIL pathway-inducing compound, determines its potent anti-cancer activity

Published:2014-12-30 Issue:24 Volume:5 Page:12728-12737
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wagner Jessica¹²,Kline Christina Leah¹²,Pottorf Richard S.³,Nallaganchu Bhaskara Rao³,Olson Gary L.³,Dicker David T.¹²,Allen Joshua E.⁴,El-Deiry Wafik S.¹²

Affiliation:

1. Hematology/Oncology Division and Penn State Hershey Cancer Institute, Penn State University, Hershey, PA, USA

2. Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA

3. Provid Pharmaceuticals, Inc., Monmouth Junction, NJ, USA

4. Oncoceutics, Inc., Hummelstown, PA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine–Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice;ACS Applied Materials & Interfaces;2024-05-30

2. Advances in synthetic lethality modalities for glioblastoma multiforme;Open Medicine;2024-01-01

3. NEW CHEMICAL ENTITIES ENTERING PHASE III TRIALS IN 2022;Medicinal Chemistry Reviews;2023-11-16

4. A review of the anti-tumor potential of current therapeutics targeting the mitochondrial protease ClpP in H3K27-altered, diffuse midline glioma;Neuro-Oncology;2023-08-17

5. Identification of Degradation Products of the New Anticancer Drug Substance ONC201 by Liquid Chromatography–High-Resolution Multistage Mass Spectrometry;Chemosensors;2023-05-15